169170 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types Neurological cells
Compositions Comprising Addl Receptors, Related Compositions, and Related Methods
#902AGENTS FOR PROPHYLAXIS OR TREATMENT OF NEUROLOGICAL RELATED DISEASES AND CONDITIONS
#903METHODS AND COMPOSITIONS FOR NERVE REGENERATION
#904MECHANISM OF ASTRICYTE-NEURON SIGNALING
#905METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#906FLUOROGENIC PH SENSITIVE DYES AND THEIR METHOD OF USE
#907Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
#908AXON REGENERATION FROM ADULT SENSORY NEURONS
#909AGENTS THAT REDUCE NEURONAL OVEREXCITATION
#910Methods and compositions for treating and preventing neurologic disorders
#911Methods of treating neurological conditions with hematopoeitic growth factors
#912IMMUNOASSAY FOR DETECTION AND QUANTIFICATION OF AMYLOID-beta PEPTIDES
#913RHO Family Antagonists and Their Use to Block Inhibition of Neurite Outgrowth
#914In vitro model for neuronal death
#915Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells
#916Methods of identifying a compound that increases or decreases the interaction of Hn-33 with synaptotagmin II
#917Retromer-based assays and methods for treating alzheimer's disease
#918Method for screening for agents that affect food intake
#919Methods of Distinguishing Types of Spinal Neurons Using Corl1 Gene as an Indicator
#920Modulation of neural stem cells and neural progenitor cells
#921Inhibition of tau-tau association
#922Acid ceramidase and mammalian cell survival
#923Compositions and methods for regulation of calcium-dependent signaling in brain
#924Non human animals with human-glial chimeric brains
#925Neurgulin 1 (NRG1) - ErbB4 signaling as a target for the treatment of schizophrenia
#926METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#927Methods of treating neurological conditions with hematopoeitic growth factors
#928Anti-addl antibodies and uses thereof
#929Neuronal regeneration material screening method by ex vivo model
#930METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
#931AGENT FOR INDUCING EMBRYONIC STEM CELL TO ECTODERMAL CELL, METHOD FOR OBTAINING THE SAME, AND USE OF THE SAME
#932Lipophilic dye-based fret assays for clostridal toxin activity
#933Screening method for Staufen activity in neurons
#934Methods of suppressing microglial activation
#935Methods for treating neural cell swelling
#936Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin
#937Non-invasive, in vitro functional tissue assay systems
#938Modulators of odorant receptors
#939Genetic manipulation of brain serotonin using the pet-1 transcriptional control region
#940DIFFERENTIAL LABELING OF CELLS
#941Biological sensor
#942IN VITRO-DIFFERENTIATED RETINAL GANGLION CELLS AND METHOD FOR PRODUCING SAME
#943miRNA of HSV-LAT and uses thereof
#944Method of screening for substances useful for transdifferentiation of microglia into neurons
#945Novel Sodium Channel
#946P75screening assay
#947Passaged neural stem cell-derived neuronal networks as sensing elements for detection of environmental threats
#948Method for screening neurogenic agents
#949Vegf-C or Vegf-D Materials and Methods for Stimulation of Neural Stem cells
#950Methods for determining cellular response to stimuli
#951Compositions and methods for treatment of protein misfolding diseases
#952Blood-Brain Barrier Model
#953Manipulation of brain CDP-diacylglycerol and uses thereof
#954Cancer stem cells and uses thereof
#955MODEL FOR NEURODEGENERATIVE DISEASES INVOLVING AMYLOID ACCUMULATION
#956Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases
#957Central nervous system neural progenitor cell which induces synapse-forming neurons in the spinal cord
#958NEUROTOXICITY METHODS PROCESS
#959ADDL Binding to Hippocampal Neurons
#960Method for identifying MLK inhibitors for treatment of neurological conditions
#961Method for testing a compound for a therapeutic effect and a diagnostic method
#962Methods and compositions for treating and preventing neurologic disorders
#963Methods For Idendifying Drug Targets And Modulators Of Neurons and Compositions Comprising The Same
#964Cell culture model and applications thereof
#965Multipotent neural stem cells
#966Ubiquitination of Membrane Transporters
#967Pain signaling molecules
#968Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#969Inhibition of tau-tau-association
#970Smilagenin and its use
#971Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#972Hedgehog Kinases and Their Use in Modulating Hedgehog Signaling
#973Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor
#974Methods of preventing or treating brain ischemia or brain injury
#975Lineage restricted glial precursors from the central nervous system
#976Method for the Identification of Drugs to Treat Stroke at Delayed Timepoints
#977In vivo odorant receptor systems and their uses
#978Methods and means for treating protein conformational disorders
#979Non-immunostimulatory antibody and compositions containing the same
#980Modulation of synaptic maintenance
#981Human autism susceptibility gene and uses thereof
#982Serum-free expansion of cells in culture
#983(+)-TRANS-4-(1-AMINOETHYL)-1-(4-PYRIDYCARBAMOYL)-CYCLOHEXANE AND METHOD FOR PROMOTING NEURAL GROWTH IN THE CENTRAL NERVOUS SYSTEM AND IN A PATIENT AT A SITE OF NEURONAL LESION
#984Novel chemical entities affecting neuroblastoma tumor-initiating cells
#985Compositions and methods for identifying modulators of TRPV2
#986High-affinity choline transporter
#987Detection and characterization of psychoactives using parallel multi-site assays in brain tissue
#988Method for identifying compounds for treatment of pain
#989Methods for direct visualization of active synapses
#990Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences
#991Screening of compounds for GAT2 transporter activity
#992Anti-ADDL monoclonal antibody and use thereof
#993αβδGABA-A receptors as a strategy for PMS and alcoholism
#994Melanocytes in therapy of neurodegenerative diseases
#995Peptide having hydrolase activity
#996Therapeutic curcumin derivatives
#997Methods of determining compounds useful in the treatment of bipolar disorder and methods of treating such disorders
#998Upstream control elements of the proopiomelanocortin gene and their use
#999Nogo receptor binding protein
#1000Materials and methods for screening modulators of neural regeneration
#1001Screening of compounds for CAT1 transporter activity
#1002Screening of compounds for OCT3 transporter activity
#1003Methods of modulating the activity of TANGO332
#1004High throughput use-dependent assay based on stimulation of cells on a silicon surface
#1005Assays for sensory modulators using a sensory cell specific G-protein beta subunit
#1006Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#1007Lineage restricted glial precursors
#1008Human secreted proteins
#1009Novel nerve stem cell marker
#1010Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1
#1011Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using electrodes with microvoltammetry
#1012Methods for assaying for antidepressant therapy markers
#1013Detection of transmembrane potentials by optical methods
#1014Purposeful movement of human migratory cells away from an agent source
#1015Method for the generation of neural progenitor cells
#1016DETECTING ELECTRICAL ACTIVITY AND ASSESSING AGENTS FOR THE ABILITY TO INFLUENCE ELECTRICAL ACTIVITY
#1017123 human secreted proteins
#1018Methods for identifying agents and conditions that modulate neurogenesis
#1019Compositions and methods for nerve regeneration
#1020Methods and kits for drug screening and toxicity testing using promoter-reporter cells derived from embryonic stem cells
#1021Psychotropic drug screening device based on long-term photoconductive stimulation of neurons
#1022Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof
#1023Methods and compositions for defining gene function
#1024In vivo modulation of neuronal transport
#1025Cells and methods for estimation of effects on neurological dysfunction
#1026Benzimidazole-carboxamide compounds as 5-HT, receptor agonists
#1027Diagnostic kit for hirschsprung disease (Congenital Megacolon)
#1028Screening method of substance with antidepressant action
#1029Neuroprotective effects of atf6
#1030Therapeutic agent for Abeta related disorders
#1031Anti-ADDL antibodies and uses thereof
#1032Assays for detecting small nuclear ribonucleoprotein particle assembly and survival of motor neurons activity
#1033Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
#1034Transcription activation complex and utilization thereof
#1035Ion channel assay methods
#1036Ion channel assay methods
#1037Prevention and treatment of amyloid-associated disorders
#1038Antagonizing nk-1 receptors inhibits consumption of substances of abuse
#1039Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-R
#1040Methods for determining cellular response to stimuli
#1041In vitro-differentiated retinal ganglion cells and method for producing same
#1042Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#1043Signaling intermediates in an in vitro model of Alzheimer's disease
#1044Methods of screening for modulators of nerve growth factor
#1045Circuit and method to non-invasively detect the electrical potential of a cell or neuron
#1046Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules
#1047Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin
#1048Olfactory receptor expression libraries and methods of making and using them
#1049Method for evaluation of endocrine disruptive action
#1050Screening methods for cognitive enhancers
#1051Modulators that promote cell surface expression of odorant receptors
#1052Teneurin c-terminal associated peptides (TCAP) and uses thereof
#1053Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor
#1054Promoter sequences for corticotropin releasing-factor receptor CRF2α and method of identifying agents that alter the activity of the promoter sequences
#1055Na+ and CI-coupled transport system for endogenous opioid peptides
#1056Inhibition of tau-tau-association
#1057System for cell-based screening
#1058Methods of suppressing microglial activation
#105915625 receptor, a novel G-protein coupled receptor
#1060Inducible inactivation of synaptic transmission
#1061Method of identifying transmembrane protein-interacting compounds
#1062Methods and compositions for the treatment and diagnosis of pain disorders using 46566
#1063Modulators of paraptosis and related methods
#1064Persephin specific antibodies
#1065Compositions and methods for promoting nerve regeneration
#1066Modulation of complement to treat pain
#1067Methods of identifying agents that mediate polypeptide aggregation
#1068Mammalian agmatinase inhibitory substance
#1069Mitigating symptoms and behaviors of substance abuse by modulating GDNF or BDNF pathway activity
#1070Assay for therapies that inhibit expression of the cytosolic Cu/Zn superoxide dismutase (SOD1) gene
#1071Method for selectively inhibiting ghrelin action
#1072Methods for treating neural cell swelling
#1073Multi-parameter high throughput screening assays (MPHTS)
#1074Use of asc-1 inhibitors to treat neurological and psychiatric disorders
#1075VPS35-based assays and methods for treating Alzheimer's disease
#1076Cell cultures from animal models of Alzheimer's disease for screening and testing drug efficacy
#1077Sleep genes in Drosophila and their use for the screening, diagnosis and therapy of sleep disorders
#1078Assay for toxin induced neuronal degeneration and viability in
#1079Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
#1080Altering memory by affecting STAUFEN function
#1081Marker for antidepressant therapy and methods related thereto
#1082Compositions and method for regulation of calcium-dependent signaling in brain
#1083Methods of treating neurological conditions with hematopoietic growth factors
#1084Method for isolation and replication of infectious human hepatitis-C virus
#1085PNS cell lines and methods of use therefor
#1086Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
#1087Use of peptide fragments of the calcium channel a-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
#1088Monitoring circadian activity
#1089SPRR1A and axonal regeneration
#1090Methods and compositions for nerve regeneration
#1091Pain signaling molecules
#1092Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds
#1093Identification of genotype-selective agents for treating Huntington's disease
#1094Neural cell assay
#1095PDE 10 cell-based assay and sequences
#1096Methods for modulating gap junctions
#1097Stem cell-based methods for identifying and characterizing agents
#1098Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
#1099Psychoactive compound associated markers and method of use thereof
#1100Device with recessed tracks for forming a cellular network
#1101Three-dimensional human stem cell-derived cortical spheroid model
#1102Devices and methods to monitor HIV-infection in presence of substance of abuse and/or therapeutic agent
#1103Functional astrocytes and cortical neurons from induced pluripotent stem cells and methods of use thereof
#1104Device and method for concomitant ejection and suction of perfusate
#1105Methods of treating epilepsy using neural stem cells that express nanog, SSEA-4, OCT-4, MIR-34B, MIR-34C and MIR-592